BlackRock Institutional Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.2M Buy
940,753
+104,002
+12% +$1.47M ﹤0.01% 2195
2016
Q3
$12.8M Buy
836,751
+48,008
+6% +$1.94M ﹤0.01% 2187
2016
Q2
$30.6M Buy
788,743
+67,349
+9% +$2.42M 0.01% 1557
2016
Q1
$20.1M Buy
721,394
+35,196
+5% +$1.17M ﹤0.01% 1831
2015
Q4
$36.9M Buy
686,198
+135,440
+25% +$6.83M 0.01% 1449
2015
Q3
$22.1M Buy
550,758
+35,069
+7% +$1.14M ﹤0.01% 1772
2015
Q2
$16.5M Buy
515,689
+54,965
+12% +$1.39M ﹤0.01% 2056
2015
Q1
$11M Buy
460,724
+275,467
+149% +$6.17M ﹤0.01% 2337
2014
Q4
$3.27M Sell
185,257
-1,204
-0.6% -$18.8K ﹤0.01% 2904
2014
Q3
$2.56M Sell
186,461
-13,187
-7% -$198K ﹤0.01% 2969
2014
Q2
$3.37M Buy
199,648
+193,554
+3,176% +$3.2M ﹤0.01% 2952
2014
Q1
$111K Buy
+6,094
New +$110K ﹤0.01% 3760

Other funds holding ITCI